Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
(4-fluorophenyl)(pyridin-4-yl)methanone is a small molecule belonging to the class of aryl phenylketones, characterized by a fluorinated phenyl group and a pyridine ring linked via a ketone. It has been studied as an experimental compound and is known to act as an inhibitor of leukotriene A–four hydrolase, an enzyme involved in the biosynthesis of pro-inflammatory leukotriene B₄. There are no approved indications or marketed formulations for this compound[1][2][3]. Its primary mechanism suggests potential anti-inflammatory activity through modulation of leukotriene pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on (4-fluorophenyl)(pyridin-4-yl)methanone.